These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 29655510)

  • 1. Histopathological validation of optical coherence tomography findings of the coronary arteries.
    Fujii K; Kawakami R; Hirota S
    J Cardiol; 2018 Sep; 72(3):179-185. PubMed ID: 29655510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ex vivo assessment of neointimal characteristics after drug-eluting stent implantation: Optical coherence tomography and histopathology validation study.
    Imanaka T; Fujii K; Hao H; Shibuya M; Saita T; Kawakami R; Fukunaga M; Kawai K; Tamaru H; Miki K; Horimatsu T; Sumiyoshi A; Nishimura M; Hirota S; Masuyama T; Ishihara M
    Int J Cardiol; 2016 Oct; 221():1043-7. PubMed ID: 27447812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thin-cap fibroatheroma and large calcification at the proximal stent edge correlate with a high proportion of uncovered stent struts in the chronic phase.
    Ueda T; Uemura S; Watanabe M; Dote Y; Goryo Y; Sugawara Y; Soeda T; Okayama S; Kawata H; Kawakami R; Okura H; Saito Y
    Coron Artery Dis; 2016 Aug; 27(5):376-84. PubMed ID: 27164267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized comparison of stent strut coverage following angiography- or optical coherence tomography-guided percutaneous coronary intervention.
    Kim JS; Shin DH; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
    Rev Esp Cardiol (Engl Ed); 2015 Mar; 68(3):190-7. PubMed ID: 25487222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optical coherence tomography assessment of in vivo vascular response after implantation of overlapping bare-metal and drug-eluting stents.
    Guagliumi G; Musumeci G; Sirbu V; Bezerra HG; Suzuki N; Fiocca L; Matiashvili A; Lortkipanidze N; Trivisonno A; Valsecchi O; Biondi-Zoccai G; Costa MA;
    JACC Cardiovasc Interv; 2010 May; 3(5):531-9. PubMed ID: 20488410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Very early tissue coverage after drug-eluting stent implantation: an optical coherence tomography study.
    Takahara M; Kitahara H; Nishi T; Miura K; Miyayama T; Sugimoto K; Nakayama T; Fujimoto Y; Kobayashi Y
    Int J Cardiovasc Imaging; 2017 Jan; 33(1):25-30. PubMed ID: 27601229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biolimus-a9 eluting stent implantion for unprotected left main coronary artery stenosis: 9-month strut coverage as assessed by optical coherence tomography.
    Taglieri N; Ghetti G; Saia F; Moretti C; Gallo P; Dall'Ara G; Palmerini T; Marrozzini C; Rapezzi C; Marzocchi A
    J Invasive Cardiol; 2015 Feb; 27(2):70-7. PubMed ID: 25661757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optical coherence tomography analysis of the stent strut and prediction of resolved strut malapposition at 3 months after 2nd-generation drug-eluting stent implantation.
    Izumi D; Miyahara M; Fujimoto N; Fukuoka S; Sakai M; Dohi K; Ito M
    Heart Vessels; 2016 Aug; 31(8):1247-56. PubMed ID: 26334709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optical coherence tomography-guided percutaneous coronary intervention: a review of current clinical applications.
    Kurogi K; Ishii M; Yamamoto N; Yamanaga K; Tsujita K
    Cardiovasc Interv Ther; 2021 Apr; 36(2):169-177. PubMed ID: 33454867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-eluting stent implantation in patients with acute coronary syndrome - the Activity of Platelets after Inhibition and Cardiovascular Events: Optical Coherence Tomography (APICE OCT) study.
    Chieffo A; Buchanan GL; Parodi G; Versaci F; Bianchi RM; Valenti R; Saccà S; Mongiardo A; Span S; Migliorini A; Spaccarotella C; Reimers B; Antoniucci D; Indolfi C; Ferrari A; Maehara A; Mintz GS; Colombo A
    EuroIntervention; 2014 Dec; 10(8):916-23. PubMed ID: 24974806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of optical coherence tomography in percutaneous coronary intervention.
    Kubo T; Tanaka A; Kitabata H; Ino Y; Tanimoto T; Akasaka T
    Circ J; 2012; 76(9):2076-83. PubMed ID: 22850338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optical coherence tomography evaluation of late strut coverage patterns between first-generation drug-eluting stents and everolimus-eluting stent.
    Toledano Delgado FJ; Alvarez-Ossorio MP; de Lezo Cruz-Conde JS; Bellido FM; Romero Moreno MÁ; Fernández-Aceytuno AM; de Lezo Herrerosde Tejada JS; Pineda SO; Saint-Gerons JM; Pavlovic D
    Catheter Cardiovasc Interv; 2014 Nov; 84(5):720-6. PubMed ID: 24174291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serial assessment of vessel interactions after drug-eluting stent implantation in unprotected distal left main coronary artery disease using frequency-domain optical coherence tomography.
    Fujino Y; Attizzani GF; Bezerra HG; Wang W; Tahara S; Yamamoto H; Chamie D; Kanaya T; Mehanna E; Takagi K; Nakamura S; Costa MA
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1035-45. PubMed ID: 24156964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morphological, Functional, and Biological Vascular Healing Response 6 Months After Drug-Eluting Stent Implantation: A Randomized Comparison of Three Drug-Eluting Stents.
    Nakata T; Fujii K; Fukunaga M; Shibuya M; Kawai K; Kawasaki D; Naito Y; Ohyanagi M; Masuyama T
    Catheter Cardiovasc Interv; 2016 Sep; 88(3):350-7. PubMed ID: 26526816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optical Coherence Tomography Guided Percutaneous Coronary Intervention With Nobori Stent Implantation in Patients With Non-ST-Segment-Elevation Myocardial Infarction (OCTACS) Trial: Difference in Strut Coverage and Dynamic Malapposition Patterns at 6 Months.
    Antonsen L; Thayssen P; Maehara A; Hansen HS; Junker A; Veien KT; Hansen KN; Hougaard M; Mintz GS; Jensen LO
    Circ Cardiovasc Interv; 2015 Aug; 8(8):e002446. PubMed ID: 26253735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serial assessment by optical coherence tomography of early and late vascular responses after implantation of an absorbable-coating Sirolimus-Eluting stent (from the first-in-human DESSOLVE I trial).
    Attizzani GF; Bezerra HG; Ormiston J; Wang W; Donohoe D; Wijns W; Costa MA
    Am J Cardiol; 2013 Nov; 112(10):1557-64. PubMed ID: 23992957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation in 3 months duration of neointimal coverage after zotarolimus-eluting stent implantation by optical coherence tomography: the ENDEAVOR OCT trial.
    Kim JS; Jang IK; Fan C; Kim TH; Kim JS; Park SM; Choi EY; Lee SH; Ko YG; Choi D; Hong MK; Jang Y
    JACC Cardiovasc Interv; 2009 Dec; 2(12):1240-7. PubMed ID: 20129551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determinants and long-term outcomes of largely uncovered struts in thin-struts drug-eluting stents assessed by optical coherence tomography.
    Moretti F; Bernelli C; Pellegrini D; Boccuzzi G; Colombo F; Sirbu V; Vassileva A; Fiocca L; Canova P; Bezerra H; Pereira GTR; Cereda A; De Luca L; Saia F; Capodanno D; Guagliumi G
    Catheter Cardiovasc Interv; 2022 Nov; 100 Suppl 1():S25-S35. PubMed ID: 36661369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three- and 6-month optical coherence tomographic surveillance following percutaneous coronary intervention with the Angiolite® drug-eluting stent: The ANCHOR study.
    Puri R; Otaegui I; Sabaté M; Serra-Peñaranda A; Puigfel M; Perez de Prado A; Nombela-Franco L; de la Torre Hernandez JM; Ortas Nadal R; Iniguez-Romo A; Jiménez G; Fernandez-Vazquez F; Cuellas-Ramon C; Gonzalo N; Alfonso Jiménez Diaz V; Duocastella L; Molina M; Amoros M; Perez I; Barria Perez A; Pelletier Beaumont E; Nicholls SJ; Garcia Del Blanco B; Rodés-Cabau J
    Catheter Cardiovasc Interv; 2018 Feb; 91(3):435-443. PubMed ID: 28707379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optical coherence tomography findings after chronic total occlusion interventions: Insights from the "AngiographiC evaluation of the everolimus-eluting stent in chronic Total occlusions" (ACE-CTO) study (NCT01012869).
    Sherbet DP; Christopoulos G; Karatasakis A; Danek BA; Kotsia A; Navara R; Michael TT; Roesle M; Rangan BV; Haagen D; Garcia S; Maniu C; Pershad A; Abdullah SM; Hastings JL; Kumbhani DJ; Luna M; Addo T; Banerjee S; Brilakis ES
    Cardiovasc Revasc Med; 2016; 17(7):444-449. PubMed ID: 27133499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.